Psoriasis Latest Advances

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Journal: The Journal of dermatological treatment

Published: January 23, 2026

Psoriatic arthritis and psoriasis have comparable cardiovascular outcomes: Results from a TriNetX Global Network cohort analysis.

Journal: JAAD international

Published: January 21, 2026

Association between out-of-pocket costs and treatment patterns in psoriasis and psoriatic arthritis: A claims-based cohort study.

Journal: JAAD international

Published: January 21, 2026

Burden of acne vulgaris, psoriasis, atopic dermatitis, and urticaria in individuals under 20 years of age in China and globally, 1990-2021: A systematic analysis with 10-year forecast.

Journal: JAAD international

Published: January 21, 2026

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Journal: Skin therapy letter

Published: January 20, 2026

Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial.

Journal: JAAD international

Published: January 19, 2026

Response of recalcitrant Blaschkoid psoriasis to bimekizumab: A case report.

Journal: JAAD case reports

Published: January 19, 2026

Network pharmacology-based elucidation of the regulatory mechanism of Solanum lyratum (Bai Ying) against psoriasis via the IL-17A/STAT3 axis: Molecular docking and HaCaT cell validation.

Journal: Pakistan journal of pharmaceutical sciences

Published: January 17, 2026

Corrigendum to "Genetic analysis of potential biomarkers and therapeutic targets in hypoxia and pyroptosis from psoriasis" [Biochem. Biophys. Rep. 44 (2025) 102314].

Journal: Biochemistry and biophysics reports

Published: January 16, 2026

Treatment Outcomes in CARD14-Associated Papulosquamous Eruption: A Systematic Review.

Journal: Journal of cutaneous medicine and surgery

Published: January 16, 2026

Lebrikizumab-induced psoriasis in a patient with atopic dermatitis.

Journal: JAAD case reports

Published: January 16, 2026

Adalimumab treatment for scalp psoriasis after hair transplantation.

Journal: Italian journal of dermatology and venereology

Published: January 16, 2026